4.2 Review

Structure, Function, and Pharmacology of NMDA Receptor Channels

期刊

PHYSIOLOGICAL RESEARCH
卷 63, 期 -, 页码 S191-S203

出版社

ACAD SCIENCES CZECH REPUBLIC, INST PHYSIOLOGY
DOI: 10.33549/physiolres.932678

关键词

Glutamate receptor; NMDA receptor; Ion channel; Channel blocker; Pharmacology; Synaptic transmission

资金

  1. Grant Agency of the Czech Republic [P303/11/0075, P304/12/G069, P303/12/1464, P303/11/P391]
  2. Marie Curie International Reintegration Grant [PIRG-GA-2010-276827]
  3. BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences from the European Regional Development Fund
  4. Charles University from the European Regional Development Fund [CZ.1.05/1.1.00/02.0109]
  5. Grant Agency of Charles University [GAUK 800313]
  6. [TE 01020028]
  7. [RVO:67985823]
  8. [CZ.1.07/2.3./00/30.0025]

向作者/读者索取更多资源

NMDA receptors have received much attention over the last few decades, due to their role in many types of neural plasticity on the one hand, and their involvement in excitotoxicity on the other hand. There is great interest in developing clinically relevant NMDA receptor antagonists that would block excitotoxic NMDA receptor activation, without interfering with NMDA receptor function needed for normal synaptic transmission and plasticity. This review summarizes current understanding of the structure of NMDA receptors and the mechanisms of NMDA receptor activation and modulation, with special attention given to data describing the properties of various types of NMDA receptor inhibition. Our recent analyses point to certain neurosteroids as NMDA receptor inhibitors with desirable properties. Specifically, these compounds show use-dependent but voltage-independent block, that is predicted to preferentially target excessive tonic NMDA receptor activation. Importantly, neurosteroids are also characterized by use-independent unblock, compatible with minimal disruption of normal synaptic transmission. Thus, neurosteroids are a promising class of NMDA receptor modulators that may lead to the development of neuroprotective drugs with optimal therapeutic profiles.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据